Clinical Trials Logo
  1. Home
  2. Prevention & Control
  3. NCT01776424

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease — COMPASS  

Prevention & Control Clinical Trial

Official title:
A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).

Clinical Trial Summary

The primary objectives of this study are: - To determine whether rivaroxaban 2.5 mg twice daily (bid) + aspirin 100 mg once daily (od) compared with aspirin 100 mg od reduces the risk of a composite of myocardial infarction, stroke, or cardiovascular death in subjects with coronary artery disease (CAD) or peripheral artery disease (PAD); - To determine whether rivaroxaban 5 mg bid compared with aspirin 100 mg od reduces the risk of a composite of myocardial infarction, stroke or cardiovascular death in subjects with CAD or PAD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01776424
Study type Interventional
Source Bayer
Contact
Status Completed
Phase Phase 3
Start date February 28, 2013
Completion date June 15, 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04062578 - Effects Provided by a Physiotherapy Treatment Preventing Lower Extremity Injuries in Female Football Players N/A
Not yet recruiting NCT04400019 - Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM) Phase 2/Phase 3
Completed NCT00793455 - Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders N/A
Completed NCT00563264 - KAN-DO: A Family-based Intervention to Prevent Childhood Obesity N/A
Completed NCT05261152 - S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections Phase 4
Completed NCT02165709 - Cohort Study of Risk Reducing Salpingectomy N/A
Recruiting NCT06164600 - Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children Phase 2
Completed NCT05365737 - Substantivity of Oral Rinses: Comparative Study N/A
Enrolling by invitation NCT02580279 - Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuvant Radiotherapy Phase 2
Recruiting NCT01747278 - Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients Phase 2/Phase 3
Enrolling by invitation NCT02577393 - Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy Phase 2
Withdrawn NCT01137591 - Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever N/A